2425 related articles for article (PubMed ID: 7549602)
1. Immunohistochemical techniques: the effect of melanin bleaching.
Foss AJ; Alexander RA; Jefferies LW; Lightman S
Br J Biomed Sci; 1995 Mar; 52(1):22-5. PubMed ID: 7549602
[TBL] [Abstract][Full Text] [Related]
2. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
Kligora CJ; Fair KP; Clem MS; Patterson JW
Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
[TBL] [Abstract][Full Text] [Related]
3. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms.
Orchard GE; Calonje E
Am J Dermatopathol; 1998 Aug; 20(4):357-61. PubMed ID: 9700373
[TBL] [Abstract][Full Text] [Related]
4. The immunoalkaline phosphatase technique in immunohistochemistry: the effect of permanganate-oxalate melanin bleaching upon four final reaction products.
Alexander RA; Cree IA; Foss AJ
Br J Biomed Sci; 1996 Jun; 53(2):170-1. PubMed ID: 8757696
[TBL] [Abstract][Full Text] [Related]
5. Heavily pigmented melanocytic neoplasms: comparison of two melanin-bleaching techniques and subsequent immunohistochemical staining.
Orchard GE
Br J Biomed Sci; 1999; 56(3):188-93. PubMed ID: 10824327
[TBL] [Abstract][Full Text] [Related]
6. The effect of melanin pigment removal on the peroxidase-antiperoxidase immunoperoxidase technic.
McGovern J; Crocker J
Am J Clin Pathol; 1987 Oct; 88(4):480-3. PubMed ID: 3310609
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology.
Kivelä T
Br J Biomed Sci; 1995 Dec; 52(4):325-6. PubMed ID: 8555789
[No Abstract] [Full Text] [Related]
8. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis.
Momose M; Ota H; Hayama M
Pathol Int; 2011 Jun; 61(6):345-50. PubMed ID: 21615609
[TBL] [Abstract][Full Text] [Related]
10. Melanin bleaching with dilute hydrogen peroxide: a simple and rapid method.
Liu CH; Lin CH; Tsai MJ; Chen WT; Chai CY; Huang YC; Tsai KB
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):275-9. PubMed ID: 23060296
[TBL] [Abstract][Full Text] [Related]
11. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy.
Taatjes DJ; Arendash-Durand B; von Turkovich M; Trainer TD
Arch Pathol Lab Med; 1993 Mar; 117(3):264-8. PubMed ID: 8442672
[TBL] [Abstract][Full Text] [Related]
12. Study of melanin bleaching after immunohistochemistry of melanin-containing tissues.
Shen H; Wu W
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):303-7. PubMed ID: 24710084
[TBL] [Abstract][Full Text] [Related]
13. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical demonstration of S 100 protein in melanin-producing tumors after bleaching for melanin].
Kaneoka A; Takasu K; Amawashi T
Rinsho Byori; 1987 Mar; 35(3):316-8. PubMed ID: 3302406
[No Abstract] [Full Text] [Related]
15. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
[TBL] [Abstract][Full Text] [Related]
16. Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin and Immunohistochemical Staining.
Wang L; Wang G
Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):53-59. PubMed ID: 37855438
[TBL] [Abstract][Full Text] [Related]
17. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
18. Construction of hematoxylin-eosin, immunohistochemistry, and EBER-ISH methodology after trichloroisocyanuric acid treatment in melanin-containing tissues.
Wang C; Yang X; Wang T; Wang Y; Shi J; Sun Q; Wang Y; Wu H
Sci Rep; 2022 Sep; 12(1):16062. PubMed ID: 36163422
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
20. Semi-automated standardisation of melanin bleaching procedures of heavily pigmented melanocytic lesions for immunohistochemical analysis on an automated platform.
Orchard GE; Gabriel J; Shams M; Fernando P; Satoc J; Nwokie T; Ismail F; d'Amico C
Br J Biomed Sci; 2019 Oct; 76(4):172-177. PubMed ID: 31144600
[No Abstract] [Full Text] [Related]
[Next] [New Search]